Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina L Porter

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Seminars in Cutaneous Medicine and Surgery|May 25, 2017
Comorbidities of hidradenitis suppurativaMartina L Porter, Alexa B Kimball
JAMA Dermatology|September 8, 2018
Predictions, Surprises, and the Future of the Dermatology WorkforceMartina L Porter, Alexa B Kimball
Cutis|June 7, 2021
Quantifying Itch: Measurement on the Way to ManagementMartina L Porter, Alexa B Kimball
Cutis|April 12, 2017
Hidradenitis suppurativa scoring systems: can we choose just one?Martina L Porter, Alexa B Kimball
Current Dermatology Reports|December 19, 2022
Impact of the COVID-19 Pandemic on the Delivery of Dermatological CareAlexa B Kimball, Martina L Porter
Journal of Drugs in Dermatology : JDD|August 21, 2018
Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television AdvertisementsNicole M Golbari, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|July 14, 2018
Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativaNicole M Golbari, Martina L Porter, Alexa B Kimball
Dermatology and Therapy|July 18, 2025
Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic TherapiesAmit Garg, Jennifer Hsiao, Martina L Porter, et al.
Clinical, Cosmetic and Investigational Dermatology|July 24, 2023
Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical ManagementCorey L Snyder, Stella X Chen, Martina L Porter
JAMA Dermatology|January 8, 2025
C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa: A Post Hoc Analysis of 2 Randomized Clinical TrialsSimon J Gunter, Martina L Porter, Alexa B Kimball
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Seminars in Cutaneous Medicine and Surgery|May 25, 2017
Comorbidities of hidradenitis suppurativaMartina L Porter, Alexa B Kimball
JAMA Dermatology|September 8, 2018
Predictions, Surprises, and the Future of the Dermatology WorkforceMartina L Porter, Alexa B Kimball
Cutis|June 7, 2021
Quantifying Itch: Measurement on the Way to ManagementMartina L Porter, Alexa B Kimball
Cutis|April 12, 2017
Hidradenitis suppurativa scoring systems: can we choose just one?Martina L Porter, Alexa B Kimball
Current Dermatology Reports|December 19, 2022
Impact of the COVID-19 Pandemic on the Delivery of Dermatological CareAlexa B Kimball, Martina L Porter
Journal of Drugs in Dermatology : JDD|August 21, 2018
Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television AdvertisementsNicole M Golbari, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|July 14, 2018
Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativaNicole M Golbari, Martina L Porter, Alexa B Kimball
Dermatology and Therapy|July 18, 2025
Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic TherapiesAmit Garg, Jennifer Hsiao, Martina L Porter, et al.
Clinical, Cosmetic and Investigational Dermatology|July 24, 2023
Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical ManagementCorey L Snyder, Stella X Chen, Martina L Porter
JAMA Dermatology|January 8, 2025
C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa: A Post Hoc Analysis of 2 Randomized Clinical TrialsSimon J Gunter, Martina L Porter, Alexa B Kimball
Pageof 7